Cargando…

Physical Inactivity in Pulmonary Sarcoidosis

PURPOSE: Reduced physical activity in many chronic diseases is consistently associated with increased morbidity. Little is known about physical activity in sarcoidosis. The aim of this study was to objectively assess physical activity in patients with pulmonary sarcoidosis and investigate its relati...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Peter S. P., Vasudevan, Sharmila, Maddocks, Matthew, Spinou, Arietta, Chamberlain Mitchell, Sarah, Wood, Claire, Jolley, Caroline J., Birring, Surinder S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520325/
https://www.ncbi.nlm.nih.gov/pubmed/30888492
http://dx.doi.org/10.1007/s00408-019-00215-6
_version_ 1783418717568237568
author Cho, Peter S. P.
Vasudevan, Sharmila
Maddocks, Matthew
Spinou, Arietta
Chamberlain Mitchell, Sarah
Wood, Claire
Jolley, Caroline J.
Birring, Surinder S.
author_facet Cho, Peter S. P.
Vasudevan, Sharmila
Maddocks, Matthew
Spinou, Arietta
Chamberlain Mitchell, Sarah
Wood, Claire
Jolley, Caroline J.
Birring, Surinder S.
author_sort Cho, Peter S. P.
collection PubMed
description PURPOSE: Reduced physical activity in many chronic diseases is consistently associated with increased morbidity. Little is known about physical activity in sarcoidosis. The aim of this study was to objectively assess physical activity in patients with pulmonary sarcoidosis and investigate its relationship with lung function, exercise capacity, symptom burden, and health status. METHODS: Physical activity was assessed over one week in 15 patients with pulmonary sarcoidosis and 14 age-matched healthy controls with a tri-axial accelerometer (ActivPal™) and the International Physical Activity Questionnaire (IPAQ). All participants underwent pulmonary function tests, 6-min walk test (6MWT) and completed the Fatigue Assessment Scale (FAS), Medical Research Council (MRC) Dyspnoea Scale and the King’s Sarcoidosis Questionnaire (KSQ). RESULTS: Patients with sarcoidosis had significantly lower daily step counts than healthy controls; mean (SD) 5624 (1875) versus 10,429 (2942) steps (p < 0.01) and a trend towards fewer sit-to-stand transitions each day (p = 0.095). Only two patients (13%) self-reported undertaking vigorous physical activity (IPAQ) compared to half of healthy individuals (p < 0.01). Daily step count was significantly associated with 6MWT distance in sarcoidosis (r = 0.634, p = 0.01), but not with forced vital capacity (r = 0.290), fatigue (r = 0.041), dyspnoea (r = −0.466) or KSQ health status (r = 0.099–0.484). Time spent upright was associated with fatigue (r = −0.630, p = 0.012) and health status (KSQ Lung scores r = 0.524, p = 0.045), and there was a significant correlation between the number of sit-to-stand transitions and MRC dyspnoea score (r = −0.527, p = 0.044). CONCLUSION: Physical activity is significantly reduced in sarcoidosis and is associated with reduced functional exercise capacity (6MWD). Fatigue, exertional symptoms and health status were more closely associated with time spent upright and the number of bouts of physical activity, as compared to step counts. Further studies are warranted to identify the factors that determine different physical activity profiles in sarcoidosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00408-019-00215-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6520325
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-65203252019-06-05 Physical Inactivity in Pulmonary Sarcoidosis Cho, Peter S. P. Vasudevan, Sharmila Maddocks, Matthew Spinou, Arietta Chamberlain Mitchell, Sarah Wood, Claire Jolley, Caroline J. Birring, Surinder S. Lung Interstitial Lung Disease PURPOSE: Reduced physical activity in many chronic diseases is consistently associated with increased morbidity. Little is known about physical activity in sarcoidosis. The aim of this study was to objectively assess physical activity in patients with pulmonary sarcoidosis and investigate its relationship with lung function, exercise capacity, symptom burden, and health status. METHODS: Physical activity was assessed over one week in 15 patients with pulmonary sarcoidosis and 14 age-matched healthy controls with a tri-axial accelerometer (ActivPal™) and the International Physical Activity Questionnaire (IPAQ). All participants underwent pulmonary function tests, 6-min walk test (6MWT) and completed the Fatigue Assessment Scale (FAS), Medical Research Council (MRC) Dyspnoea Scale and the King’s Sarcoidosis Questionnaire (KSQ). RESULTS: Patients with sarcoidosis had significantly lower daily step counts than healthy controls; mean (SD) 5624 (1875) versus 10,429 (2942) steps (p < 0.01) and a trend towards fewer sit-to-stand transitions each day (p = 0.095). Only two patients (13%) self-reported undertaking vigorous physical activity (IPAQ) compared to half of healthy individuals (p < 0.01). Daily step count was significantly associated with 6MWT distance in sarcoidosis (r = 0.634, p = 0.01), but not with forced vital capacity (r = 0.290), fatigue (r = 0.041), dyspnoea (r = −0.466) or KSQ health status (r = 0.099–0.484). Time spent upright was associated with fatigue (r = −0.630, p = 0.012) and health status (KSQ Lung scores r = 0.524, p = 0.045), and there was a significant correlation between the number of sit-to-stand transitions and MRC dyspnoea score (r = −0.527, p = 0.044). CONCLUSION: Physical activity is significantly reduced in sarcoidosis and is associated with reduced functional exercise capacity (6MWD). Fatigue, exertional symptoms and health status were more closely associated with time spent upright and the number of bouts of physical activity, as compared to step counts. Further studies are warranted to identify the factors that determine different physical activity profiles in sarcoidosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00408-019-00215-6) contains supplementary material, which is available to authorized users. Springer US 2019-03-19 2019 /pmc/articles/PMC6520325/ /pubmed/30888492 http://dx.doi.org/10.1007/s00408-019-00215-6 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Interstitial Lung Disease
Cho, Peter S. P.
Vasudevan, Sharmila
Maddocks, Matthew
Spinou, Arietta
Chamberlain Mitchell, Sarah
Wood, Claire
Jolley, Caroline J.
Birring, Surinder S.
Physical Inactivity in Pulmonary Sarcoidosis
title Physical Inactivity in Pulmonary Sarcoidosis
title_full Physical Inactivity in Pulmonary Sarcoidosis
title_fullStr Physical Inactivity in Pulmonary Sarcoidosis
title_full_unstemmed Physical Inactivity in Pulmonary Sarcoidosis
title_short Physical Inactivity in Pulmonary Sarcoidosis
title_sort physical inactivity in pulmonary sarcoidosis
topic Interstitial Lung Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520325/
https://www.ncbi.nlm.nih.gov/pubmed/30888492
http://dx.doi.org/10.1007/s00408-019-00215-6
work_keys_str_mv AT chopetersp physicalinactivityinpulmonarysarcoidosis
AT vasudevansharmila physicalinactivityinpulmonarysarcoidosis
AT maddocksmatthew physicalinactivityinpulmonarysarcoidosis
AT spinouarietta physicalinactivityinpulmonarysarcoidosis
AT chamberlainmitchellsarah physicalinactivityinpulmonarysarcoidosis
AT woodclaire physicalinactivityinpulmonarysarcoidosis
AT jolleycarolinej physicalinactivityinpulmonarysarcoidosis
AT birringsurinders physicalinactivityinpulmonarysarcoidosis